Cancer Sera Induces Resistance to Natural Killer Cell Cytotoxicity
Author Information
Author(s): M. Marubayashi, R. Solana, R. Ramirez, E. Aranda, F. Galan, J. Peinal
Primary Institution: Reina Sofia Hospital and University of Córdoba
Hypothesis
Do sera from cancer patients induce resistance to NK cell cytotoxicity?
Conclusion
Sera from patients with metastatic cancers significantly induce resistance to NKCF lysis in K562 cells.
Supporting Evidence
- 77% of patients' sera induced resistance to NKCF cytotoxicity.
- Sera from metastatic cancer patients blocked NKCF lysis more than those from patients without metastasis.
- The blocking effect was not related to gamma interferon levels.
Takeaway
Patients with certain types of cancer have blood that can stop immune cells from killing cancer cells.
Methodology
Sera from cancer patients were tested for their ability to block NKCF-mediated lysis of K562 cells.
Limitations
The study does not clarify the exact mechanisms of resistance or the role of other factors.
Participant Demographics
Patients included 10 with colon cancer, 12 with breast cancer, and 5 with lung cancer.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website